Index of reports
> Disability (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Reyataz side effects in male
Reported by a physician from Japan on 2012-08-15
Patient: male
Reactions: Renal Function Test Abnormal, Hyperkalaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Combivir
Administration route: Oral
Start date: 2012-01-16
Combivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-04-01
End date: 2011-12-22
Norvir
Start date: 2011-12-24
Norvir
Indication: HIV Infection
Start date: 2005-10-06
End date: 2011-12-22
Reyataz
Dosage: 300-400 mg/day
Administration route: Oral
Indication: HIV Infection
Start date: 2004-04-01
End date: 2011-12-22
Reyataz
Dosage: 300-400 mg/day
Administration route: Oral
Start date: 2011-12-24
Other drugs received by patient: Allopurinol
Possible Reyataz side effects in 49 year old male
Reported by a physician from Japan on 2012-08-09
Patient: 49 year old male
Reactions: Renal Function Test Abnormal, Hyperkalaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Combivir
Dosage: 1apr04-22dec11 16jan12-ong
Administration route: Oral
Indication: HIV Infection
Start date: 2004-04-01
Norvir
Dosage: 06oct05-22dec11 24dec11-ong
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-06
Reyataz
Dosage: 1df: 300-400mg 01apr04-22dec11 24dec11-ong
Administration route: Oral
Indication: HIV Infection
Start date: 2004-04-01
Other drugs received by patient: Allopurinol
Possible Reyataz side effects in 41 year old female
Reported by a physician from Canada on 2012-06-29
Patient: 41 year old female
Reactions: Breast Cancer, Back Pain, Weight Increased, Breast Cancer Metastatic, Hydrocephalus, Metastases To Bone
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Lamivudine
Indication: HIV Infection
Start date: 2006-05-12
Norvir
Indication: HIV Infection
Start date: 2006-03-12
Reyataz
Indication: HIV Infection
Start date: 2006-05-12
Study Drug MK-0518 (Non-Abbott)
Dosage: blinded treatment
Administration route: Oral
Indication: HIV Infection
Start date: 2006-05-12
End date: 2009-05-13
Study Drug MK-0518 (Non-Abbott)
Administration route: Oral
Start date: 2009-03-14
End date: 2010-07-07
Viread
Indication: HIV Infection
Start date: 2006-05-12
Other drugs received by patient: Robaxin; Oxycodone HCL; Ibuprofen (Advil); Acetaminophen; Palafer; Acetaminophen; Zomig; Dilaudid
Possible Reyataz side effects in male
Reported by a physician from Japan on 2012-03-09
Patient: male, weighing 43.0 kg (94.6 pounds)
Reactions: Uveitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Intelence
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-14
End date: 2010-02-03
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2009-11-25
End date: 2010-02-03
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2009-11-25
End date: 2010-02-03
Other drugs received by patient: Zerit; Isentress; Sanilvudine; Vibramycin; Lamivudine; Epivir; Atovaquone
Possible Reyataz side effects in male
Reported by a physician from France on 2012-03-01
Patient: male
Reactions: Aphasia, Hemiplegia, Cerebrovascular Accident
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1unit per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-12-06
Reyataz
Dosage: 200mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-12-06
Other drugs received by patient: Crestor
Possible Reyataz side effects in 54 year old male
Reported by a physician from France on 2012-03-01
Patient: 54 year old male
Reactions: Dyslipidaemia, Cerebrovascular Accident
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1df:1 intake
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-12-06
Reyataz
Dosage: initially given 150mg twice daily (from 06-dec-2005) then changed to 200mg twice daily (11-mar-2009)
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-12-06
Ritonavir
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-12-06
End date: 2009-03-11
Possible Reyataz side effects in male
Reported by a physician from Japan on 2012-01-05
Patient: male, weighing 43.0 kg (94.6 pounds)
Reactions: Uveitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Intelence
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-14
End date: 2010-02-03
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2009-11-25
End date: 2010-02-03
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2009-11-25
End date: 2010-02-03
Other drugs received by patient: Isentress; Vibramycin; Atovaquone; Epivir; Zerit
|